UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 41 filers reported holding UNIQURE NV in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $873,072 | -20.6% | 130,115 | +35.6% | 0.11% | -27.2% |
| Q2 2023 | $1,099,896 | -14.1% | 95,977 | +50.9% | 0.15% | -13.2% |
| Q1 2023 | $1,280,985 | +164.0% | 63,604 | +197.2% | 0.17% | +120.3% |
| Q4 2022 | $485,161 | +97.2% | 21,401 | +57.3% | 0.08% | +276.2% |
| Q1 2022 | $246,000 | -22.4% | 13,606 | -10.9% | 0.02% | -12.5% |
| Q4 2021 | $317,000 | -47.8% | 15,269 | -9.1% | 0.02% | -41.5% |
| Q4 2020 | $607,000 | -9.3% | 16,804 | -5.1% | 0.04% | +64.0% |
| Q2 2018 | $669,000 | -78.9% | 17,700 | -86.9% | 0.02% | -76.6% |
| Q1 2018 | $3,175,000 | +16.6% | 135,100 | -2.9% | 0.11% | +35.4% |
| Q4 2017 | $2,724,000 | +119.5% | 139,065 | +129.1% | 0.08% | +182.1% |
| Q3 2015 | $1,241,000 | -13.8% | 60,692 | +13.9% | 0.03% | -26.3% |
| Q2 2015 | $1,439,000 | +212.8% | 53,300 | +182.0% | 0.04% | +245.5% |
| Q1 2015 | $460,000 | – | 18,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |